ClinVar Miner

Submissions for variant NM_032119.4(ADGRV1):c.13358A>G (p.His4453Arg)

gnomAD frequency: 0.00027  dbSNP: rs200212083
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000490059 SCV000577348 uncertain significance not provided 2018-06-21 criteria provided, single submitter clinical testing The H4453R variant in the ADGRV1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The H4453R variant is observed in 43/126528 (0.034%) alleles from individuals of non-Finnish background, in large population cohorts (Lek et al., 2016). The H4453R variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret H4453R as a variant of uncertain significance.
Fulgent Genetics, Fulgent Genetics RCV000765854 SCV000897250 uncertain significance Usher syndrome type 2C; Febrile seizures, familial, 4 2018-10-31 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000490059 SCV001225149 likely benign not provided 2024-11-11 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV001195219 SCV001365526 uncertain significance not specified 2019-06-21 criteria provided, single submitter clinical testing The p.His4453Arg variant in ADGRV1 has not been previously reported in individuals with hearing loss or Usher syndrome, but has been identified in 0.03% (48/128280) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 426807). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.